| NDC Code | 68727-745-01 |
|---|
| Package Description | 20 mL in 1 VIAL (68727-745-01) |
|---|
| Product NDC | 68727-745 |
|---|
| Product Type Name | HUMAN PRESCRIPTION DRUG |
|---|
| Proprietary Name | Vyxeos |
|---|
| Non-Proprietary Name | (daunorubicin And Cytarabine) Liposome |
|---|
| Dosage Form | INJECTION, POWDER, LYOPHILIZED, FOR SUSPENSION |
|---|
| Usage | INTRAVENOUS |
|---|
| Start Marketing Date | 20170803 |
|---|
| Marketing Category Name | NDA |
|---|
| Application Number | NDA209401 |
|---|
| Manufacturer | Jazz Pharmaceuticals, Inc. |
|---|
| Substance Name | CYTARABINE; DAUNORUBICIN |
|---|
| Strength | 100; 44 |
|---|
| Strength Unit | mg/20mL; mg/20mL |
|---|
| Pharmacy Classes | Anthracycline Topoisomerase Inhibitor [EPC], Anthracyclines [CS], Nucleic Acid Synthesis Inhibitors [MoA], Nucleoside Metabolic Inhibitor [EPC], Topoisomerase Inhibitors [MoA] |
|---|